PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

NCT01304485 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Sodium Acetate C11

Sponsor

Phoenix Molecular Imaging